| Announce Date | 10/22/2025 |
| EPS Normalized Actual | $2.11 (Beat by $0.05) |
| EPS GAAP Actual | $2.11 (Beat by $0.05) |
| Revenue Actual | $3.12B |
| Revenue Surprise | Beat by $3120M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.92714 |
| EPS GAAP Estimate | $1.92714 |
| Revenue Estimate | $2.424B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 15.8 | 18.81 | 15.00702 | 16.29803 | 1 |
| Dec 2028 | 14.34 | 20.72 | 13.65293 | 14.94213 | 3 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.79 | -0.39909 | 3.12B | 8.11% | -50.42M |
| FQ2 2025 (Jun 2025) | 1.85 | 1.85 | 3.137B | 5.93% | 3137M |
| FQ1 2025 (Mar 2025) | 1.25 | 1.25 | 2.695B | 4.53% | 2695M |
| FQ4 2024 (Dec 2024) | 2.08 | 2.08 | 2.783B | 6.25% | 2783M |
| FQ3 2024 (Sep 2024) | 1.38 | 1.38 | 2.867B | 6.77% | 2867M |
| FQ2 2024 (Jun 2024) | 1.69 | 1.69 | 2.951B | 9.86% | 2951M |
| FQ1 2024 (Mar 2024) | 1.05 | 1.05 | 2.573B | 10.88% | 2573M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 2.609B | 6.32% | 2609M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.92714
Consensus Revenue Estimates
2.424B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.64 | -- | 2.57909 | 2.73071 | 5 |
| FQ3 2027 (Sep 2027) | 2.92538 | -- | 2.83354 | 2.99033 | 8 |
| FQ2 2027 (Jun 2027) | 2.91843 | -- | 2.82681 | 2.98323 | 5 |
| FQ1 2027 (Mar 2027) | 2.25823 | -- | 2.18734 | 2.30837 | 4 |
| FQ4 2026 (Oct 2026) | 2.61951 | -- | 2.54899 | 2.70217 | 7 |
| FQ3 2026 (Jul 2026) | 2.56745 | 30.28 | 2.49833 | 2.64847 | 4 |
| FQ2 2026 (Jun 2026) | 2.56892 | 27.99 | 2.50204 | 2.67131 | 4 |
| FQ1 2026 (Mar 2026) | 1.92714 | 35.14 | 1.87697 | 2.00395 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.39B | -- | 1.36B | 1.42B | 3 |
| FQ3 2027 (Sep 2027) | 5.48B | -- | 5.35B | 5.57B | 3 |
| FQ2 2027 (Jun 2027) | 5.15B | -- | 5.03B | 5.24B | 3 |
| FQ1 2027 (Mar 2027) | 4.85B | -- | 4.73B | 4.93B | 3 |
| FQ4 2026 (Oct 2026) | 3.61B | -- | 3.54B | 3.7B | 4 |
| FQ3 2026 (Jul 2026) | 3.59B | 13.09 | 3.52B | 3.68B | 5 |
| FQ2 2026 (Jun 2026) | 2.6B | -20.56 | 2.55B | 2.68B | 5 |
| FQ1 2026 (Mar 2026) | 2.42B | -11.18 | 2.38B | 2.5B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.18909 | 1.79 | -0.39909 | -22.3% |
| FQ2 2025 (Jun 2025) | 1.85 | 1.85 | 100% | |
| FQ1 2025 (Mar 2025) | 1.25 | 1.25 | 100% | |
| FQ4 2024 (Dec 2024) | 2.08 | 2.08 | 100% | |
| FQ3 2024 (Sep 2024) | 1.38 | 1.38 | 100% | |
| FQ2 2024 (Jun 2024) | 1.69 | 1.69 | 100% | |
| FQ1 2024 (Mar 2024) | 1.05 | 1.05 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $3.17B | $3.12B | $-50.42M | -1.62% |
| FQ2 2025 (Jun 2025) | $0B | $3.14B | $3137M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $2.7B | $2695M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.78B | $2783M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.87B | $2867M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.95B | $2951M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.57B | $2573M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $2.61B | $2609M | 100% |